Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > ONCR Oncorus > Detailed Quotes

ONCR Oncorus

Watchlist
0.436
-0.014-3.11%
Close  02/03 16:00 ET
0.4360.0000.00%
Post Mkt Price 02/03 16:36 ET
High
0.470
Open
0.450
Turnover
190.31K
Low
0.420
Pre Close
0.450
Volume
425.67K
Market Cap
11.31M
P/E(TTM)
Loss
52wk High
3.200
Shares
25.97M
P/E(Static)
Loss
52wk Low
0.230
Float Cap
5.10M
Bid/Ask %
-71.43%
Historical High
37.860
Shs Float
11.71M
Volume Ratio
0.68
Historical Low
0.230
Dividend TTM
--
Div Yield TTM
--
P/B
0.14
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
3.64%
Amplitude
11.11%
Avg Price
0.447
Lot Size
1
Float Cap
5.10M
Bid/Ask %
-71.43%
Historical High
37.860
Shs Float
11.71M
Volume Ratio
0.68
Historical Low
0.230
Dividend TTM
--
P/B
0.14
Dividend LFY
--
Turnover Ratio
3.64%
Amplitude
11.11%
Avg Price
0.447
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Oncorus, Inc. engages in the research and development of a viral immunotherapy platform. It develops an immunotherapy platform to treat cancer such as oncolytic Herpes Simplex Virus Platform and Synthetic Virus Platform. The company was founded by Mitchell H. Finer, Joseph C. Glorioso III, Kenneth P. Greenberg, Cyrus D. Mozayeni, and Paola Grandi on April 1, 2015 and is headquartered in Andover, MA.
CEO: Dr. Theodore Ashburn, M.D.,PhD
Market: NASDAQ
Listing Date: 10/02/2020
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist